Developing high-throughput HIV incidence assay with pyrosequencing platform

Journal of Virology

Volumn 88, Issue 5, 2014, Pages 2977-2990

  Park, Sung Yong ^a   Goeken, Nolan ^a   Lee, Hyo Jin ^a   Bolan, Robert ^b   Dubé, Michael P ^a   Lee, Ha Youn ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LOS ANGELES LGBT CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENETIC MARKER; HIGH THROUGHPUT SCREENING; HIV INCIDENCE ASSAY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; INFECTION; MALE; MEASUREMENT ACCURACY; MEASUREMENT ERROR; MEASUREMENT PRECISION; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PYROSEQUENCING; REPRODUCIBILITY; RIBONUCLEIC ACID TEMPLATE; RNA STRUCTURE; SEQUENCING ERROR; UNINDEXED SEQUENCE; VIRUS LOAD; VIRUS REPLICATION;

ADULT; AGED; ALGORITHMS; CD4 LYMPHOCYTE COUNT; FEMALE; GENOME, VIRAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, STATISTICAL; MOLECULAR SEQUENCE DATA; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD; YOUNG ADULT;

EID: 84896713730     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03128-13     Document Type: Article

References (34)

1. Brookmeyer R. 1991. Reconstruction and future trends of the AIDS epidemic in the United States. Science 253:37-42. http://dx.doi.org/10.1126/science.2063206.
2. Busch MP, Pilcher CD, Mastro TD, Kaldor J, Vercauteren G, Rodriguez W, Rousseau C, Rehle TM, Welte A, Averill MD, Garcia Calleja JM. 2010. Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS 24:2763-2771. http://dx.doi.org/10.1097/QAD.0b013e32833f1142.
3. Mastro TD. 2013. Determining HIV incidence in populations: moving in the right direction. J. Infect. Dis. 207:204-206. http://dx.doi.org/10.1093/infdis/jis661.
4. Brookmeyer R, Quinn TC. 1995. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am. J. Epidemiol. 141:166-172.
5. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP. 1998. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280:42-48. http://dx.doi.org/10.1001/jama.280.1.42.
6. Kothe D, Byers RH, Caudill SP, Satten GA, Janssen RS, Hannon WH, Mei JV. 2003. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J. Acquir. Immune Defic. Syndr. 33:625-634. http://dx.doi.org/10.1097/00126334-200308150-00012.
7. Chawla A, Murphy G, Donnelly C, Booth CL, Johnson M, Parry JV, Phillips A, Geretti AM. 2007. Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J. Clin. Microbiol. 45:415-420. http://dx.doi.org/10.1128/JCM .01879-06.
8. Thomas HI, Wilson S, O'Toole CM, Lister CM, Saeed AM, Watkins RP, Morgan-Capner P. 1996. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Clin. Exp. Immunol. 103:185-191.
9. Guy R, Gold J, Calleja JM, Kim AA, Parekh B, Busch M, Rehle T, Hargrove J, Remis RS, Kaldor JM. 2009. Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review. Lancet Infect. Dis. 9:747-759. http://dx.doi .org/10.1016/S1473-3099(09)70300-7.
10. Dobbs T, Kennedy S, Pau CP, McDougal JS, Parekh BS. 2004. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J. Clin. Microbiol. 42:2623-2628. http://dx.doi.org /10.1128/JCM.42.6.2623-2628.2004.
11. Duong YT, Qiu M, De AK, Jackson K, Dobbs T, Kim AA, Nkengasong JN, Parekh BS. 2012. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One 7:e33328. http://dx.doi.org/10 .1371/journal.pone.0033328.
12. WHO/UNAIDS. 2013. WHO/UNAIDS technical update on HIV incidence assays for surveillance and epidemic monitoring. http://www.who.int/diagnostics_laboratory/links/hiv_incidence_assay/en/.
13. Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR, III, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH. 2013. HIV incidence determination in the United States: a multiassay approach. J. Infect. Dis. 207:232-239. http://dx.doi.org/10 .1093/infdis/jis659.
14. Park SY, Love TM, Nelson J, Thurston SW, Perelson AS, Lee HY. 2011. Designing agenome-basedHIVincidence assay with high sensitivityandspecificity. AIDS 25:F13-F19. http://dx.doi.org/10.1097/QAD.0b013e328349f089.
15. Allam O, Samarani S, Ahmad A. 2011. Hammering out HIV-1 incidence with Hamming distance. AIDS 25:2047-2048. http://dx.doi.org/10.1097 /QAD.0b013e32834bac66.
16. Ronaghi M, Uhlén M, Nyrén P. 1998. A sequencing method based on real-time pyrophosphate. Science 281:363, 365. http://dx.doi.org/10.1126 /science.281.5375.363.
17. Simen BB, Simons JF, Hullsiek KH, Novak RM, Macarthur RD, Baxter JD, Huang C, Lubeski C, Turenchalk GS, Braverman MS, Desany B, Rothberg JM, Egholm M, Kozal MJ; Terry Beirn Community Programs for Clinical Research on AIDS. 2009. Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. J. Infect. Dis. 199:693- 701. http://dx.doi.org/10.1086/596736.
18. Bimber BN, Dudley DM, Lauck M, Becker EA, Chin EN, Lank SM, Grunenwald HL, Caruccio NC, Maffitt M, Wilson NA, Reed JS, Sosman JM, Tarosso LF, Sanabani S, Kallas EG, Hughes AL, O'Connor DH. 2010. Whole-genome characterization of human and simian immunodeficiency virus intrahost diversity by ultradeep pyrosequencing. J. Virol. 84:12087-12092. http://dx.doi.org/10.1128/JVI.01378-10.
19. Cousins MM, Ou SS, Wawer MJ, Munshaw S, Swan D, Magaret CA, Mullis CE, Serwadda D, Porcella SF, Gray RH, Quinn TC, Donnell D, Eshleman SH, Redd AD. 2012. Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity. J. Clin. Microbiol. 50:3054-3059. http://dx.doi.org/10.1128/JCM.01460-12.
20. Varghese V, Shahriar R, Rhee SY, Liu T, Simen BB, Egholm M, Hanczaruk B, Blake LA, Gharizadeh B, Babrzadeh F, Bachmann MH, Fessel WJ, Shafer RW. 2009. Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors. J. Acquir. Immune Defic. Syndr. 52:309- 315. http://dx.doi.org/10.1097/QAI.0b013e3181bca669.
21. Henn MR, Boutwell CL, Charlebois P, Lennon NJ, Power KA, Macalalad AR, Berlin AM, Malboeuf CM, Ryan EM, Gnerre S, Zody MC, Erlich RL, Green LM, Berical A, Wang Y, Casali M, Streeck H, Bloom AK, Dudek T, Tully D, Newman R, Axten KL, Gladden AD, Battis L, Kemper M, Zeng Q, Shea TP, Gujja S, Zedlack C, Gasser O, Brander C, Hess C, Gunthard HF, Brumme ZL, Brumme CJ, Bazner S, Rychert J, Tinsley JP, Mayer KH, Rosenberg E, Pereyra F, Levin JZ, Young SK, Jessen H, Altfeld M, Birren BW, Walker BD, Allen TM. 2012. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog. 8:e1002529. http://dx.doi.org/10.1371/journal.ppat.1002529.
22. Eriksson N, Pachter L, Mitsuya Y, Rhee SY, Wang C, Gharizadeh B, Ronaghi M, Shafer RW, Beerenwinkel N. 2008. Viral population estimation using pyrosequencing. PLoS Comput. Biol. 4:e1000074. http://dx .doi.org/10.1371/journal.pcbi.1000074.
23. Jabara CB, Jones CD, Roach J, Anderson JA, Swanstrom R. 2011. Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID. Proc. Natl. Acad. Sci. U. S. A. 108:20166-20171. http://dx .doi.org/10.1073/pnas.1110064108.
24. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, Wei X, Jiang C, Kirchherr JL, Gao F, Anderson JA, Ping LH, Swanstrom R, Tomaras GD, Blattner WA, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Cohen MS, Montefiori DC, Haynes BF, Gaschen B, Athreya GS, Lee HY, Wood N, Seoighe C, Perelson AS, Bhattacharya T, Korber BT, Hahn BH, Shaw GM. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 105:7552-7557. http://dx.doi.org/10.1073/pnas.0802203105.
25. Abrahams MR, Anderson JA, Giorgi EE, Seoighe C, Mlisana K, Ping LH, Athreya GS, Treurnicht FK, Keele BF, Wood N, Salazar-Gonzalez JF, Bhattacharya T, Chu H, Hoffman I, Galvin S, Mapanje C, Kazembe P, Thebus R, Fiscus S, Hide W, Cohen MS, Karim SA, Haynes BF, Shaw GM, Hahn BH, Korber BT, Swanstrom R, Williamson C. 2009. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J. Virol. 83:3556-3567. http://dx.doi.org/10.1128/JVI.02132-08.
26. Bar KJ, Li H, Chamberland A, Tremblay C, Routy JP, Grayson T, Sun C, Wang S, Learn GH, Morgan CJ, Schumacher JE, Haynes BF, Keele BF, Hahn BH, Shaw GM. 2010. Wide variation in the multiplicity of HIV-1 infection among injection drug users. J. Virol. 84:6241-6247. http: //dx.doi.org/10.1128/JVI.00077-10.
27. Palmer S, Kearney M, Maldarelli F, Halvas EK, Bixby CJ, Bazmi H, Rock D, Falloon J, Davey RT, Jr, Dewar RL, Metcalf JA, Hammer S, Mellors JW, Coffin JM. 2005. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J. Clin. Microbiol. 43:406-413. http://dx.doi.org/10.1128/JCM.43.1.406-413.2005.
28. Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF, Derdeyn CA, Farmer P, Hunter E, Allen S, Manigart O, Mulenga J, Anderson JA, Swanstrom R, Haynes BF, Athreya GS, Korber BT, Sharp PM, Shaw GM, Hahn BH. 2008. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by singlegenome amplification and sequencing. J. Virol. 82:3952-3970. http://dx .doi.org/10.1128/JVI.02660-07.
29. Needleman SB, Wunsch CD. 1970. A general method applicable to the search for similarities in the amino acid sequence of two proteins. J. Mol. Biol. 48:443-453. http://dx.doi.org/10.1016/0022-2836(70)90057-4.
30. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871-1879. http://dx .doi.org/10.1097/00002030-200309050-00005.
31. Fiebig EW, Heldebrant CM, Smith RI, Conrad AJ, Delwart EL, Busch MP. 2005. Intermittent low-level viremia in very early primary HIV-1 infection. J. Acquir. Immune Defic. Syndr. 39:133-137.
32. Quinlan AR, Stewart DA, Stromberg MP, Marth GT. 2008. Pyrobayes: an improved base caller for SNP discovery in pyrosequences. Nat. Methods 5:179-181. http://dx.doi.org/10.1038/nmeth.1172.
33. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, Huang XL, Mullins JI. 1999. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73:10489-10502.
34. Andersson E, Shao W, Bontell I, Cham F, Cuong DD, Wondwossen A, Morris L, Hunt G, Sonnerborg A, Bertagnolio S, Maldarelli F, Jordan MR. 11 April 2013. Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys. Infect. Genet. Evol. http://dx.doi.org/10.1016/j.meegid .2013.03.050.